Literature DB >> 16808956

Specific interaction of CXCR4 with CD4 and CD8alpha: functional analysis of the CD4/CXCR4 interaction in the context of HIV-1 envelope glycoprotein-mediated membrane fusion.

Stéphane Basmaciogullari1, Beatriz Pacheco, Stephan Bour, Joseph Sodroski.   

Abstract

We investigated possible interactions between HIV-1 receptor (CD4) and the main coreceptors CXCR4 and CCR5. We found that CD4 and CXCR4 coexpressed in 293T cells form a complex that can be immunoprecipitated with antibodies directed against the extracellular domain of either protein. Mutagenesis revealed that the CD4/CXCR4 interaction maps to two previously uncharacterized basic motifs in the cytoplasmic domain of CD4. HIV-1 envelope glycoprotein-mediated membrane fusion was found to be independent of the ability of CD4 and CXCR4 to interact, whether fusion was studied in a virus-cell or a cell-cell model. However, this interaction might explain the adaptation of HIV-1 to CXCR4 as an alternative to CCR5. We found that CXCR4 also interacts with the cytoplasmic domain of CD8alpha in a way that is similar to the CD4/CXCR4 interaction. The CD4/CXCR4 and CD8alpha/CXCR4 interactions may thus be involved in cellular signaling pathways shared by the CD4 and CD8alpha molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808956     DOI: 10.1016/j.virol.2006.05.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

Review 2.  Modulation of chemokine receptor activity through dimerization and crosstalk.

Authors:  C L Salanga; M O'Hayre; T Handel
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

3.  Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Authors:  Nadine Laguette; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

4.  CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface.

Authors:  Laura Martínez-Muñoz; Rubén Barroso; Sunniva Y Dyrhaug; Gemma Navarro; Pilar Lucas; Silvia F Soriano; Beatriz Vega; Coloma Costas; M Ángeles Muñoz-Fernández; César Santiago; José Miguel Rodríguez Frade; Rafael Franco; Mario Mellado
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

5.  Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.

Authors:  Mikhail A Zhukovsky; Stéphane Basmaciogullari; Beatriz Pacheco; Liping Wang; Navid Madani; Hillel Haim; Joseph Sodroski
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

6.  Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase.

Authors:  Nadine Laguette; Christelle Brégnard; Jérôme Bouchet; Alexandre Benmerah; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

7.  Molecular cloning, characterization, and expression analysis of the CXCR4 gene from Turbot: Scophthalmus maximus.

Authors:  Airong Jia; Xiao-Hua Zhang
Journal:  J Biomed Biotechnol       Date:  2009-09-08

Review 8.  A biophysical perspective on receptor-mediated virus entry with a focus on HIV.

Authors:  Isabel Llorente García; Mark Marsh
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-12-19       Impact factor: 3.747

Review 9.  Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.

Authors:  Ponraj Prabakaran; Antony S Dimitrov; Timothy R Fouts; Dimiter S Dimitrov
Journal:  Adv Pharmacol       Date:  2007

Review 10.  Membrane organization of virus and target cell plays a role in HIV entry.

Authors:  Fabrice Dumas; Pascal Preira; Laurence Salomé
Journal:  Biochimie       Date:  2014-09-01       Impact factor: 4.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.